These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7459889)

  • 1. Preclinical toxicologic study of 2,3-dihydro-1H-imidazo[1,2-b] pyrazole (IMPY) in mice, dogs, and monkeys.
    Henry MC; Port CD; Rosen E; Levine BS
    Cancer Treat Rep; 1980; 64(10-11):1031-8. PubMed ID: 7459889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical toxicologic evaluation of dianhydrogalactitol in dogs and monkeys.
    Folk RM; Pavkov KL; Thake DC
    Cancer Treat Rep; 1976 Oct; 60(10):1585-9. PubMed ID: 828520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical toxicologic evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in mice, dogs, and monkeys.
    Henry MC; Port CD; Levine BS
    Cancer Treat Rep; 1980; 64(8-9):855-60. PubMed ID: 6893811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical evaluation of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole.
    Yap BS; Murphy WK; Burgess MA; Valdivieso M; Bodey GP
    Cancer Treat Rep; 1979; 63(11-12):1849-51. PubMed ID: 526919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical toxic effects of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY) with relevant pharmacokinetic parameters.
    Neidhart JA; Staubus AE; Young D; King GW; Malspeis L
    Cancer Treat Rep; 1980; 64(2-3):251-5. PubMed ID: 7407759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical toxicologic evaluation of ICRF-187 in dogs.
    Levine BS; Henry MC; Port CD; Rosen E
    Cancer Treat Rep; 1980; 64(12):1211-5. PubMed ID: 6781745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial of weekly iv 2,3-dihydro-1H-imidazo[1,2-b]pyrazole (IMPY).
    Vogel CL; Denefrio JM; Padgett DC; Silverman MA
    Cancer Treat Rep; 1980; 64(10-11):1153-6. PubMed ID: 7459903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dosing schedule dependent toxicities of adriamycin in beagle dogs and rhesus monkeys.
    Gralla EJ; Fleischman RW; Luthra YK; Stadnicki SW
    Toxicology; 1979 Aug; 13(3):263-73. PubMed ID: 118548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC; Schindler-Horvat J; Hill JR; Green CE; Mitoma C; Tomaszewski JE; Tyson CA; Donohue SJ
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and toxicokinetics of the cyclin-dependent kinase inhibitor AG-024322 in cynomolgus monkeys following intravenous infusion.
    Brown AP; Courtney CL; Criswell KA; Holliman CL; Evering W; Jessen BA
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1091-101. PubMed ID: 18509643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide.
    Germann N; Urien S; Rodgers AH; Ratterree M; Struck RF; Waud WR; Serota DG; Bastian G; Jursic BS; Morgan LR
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):143-51. PubMed ID: 15592722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA; Slavik M; Carter SK
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CCNU: preclinical toxicologic evaluation of a single iv infusion in dogs and monkeys.
    Schaeppi U; Fleischman RW; Phelan RS; Ethier MF; Luthra YK
    Cancer Treat Rep; 1976 Oct; 60(10):1559-66. PubMed ID: 828519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical toxicologic evaluation of tetrahydrouridine (NSC-112907) in beagle dogs and rhesus monkeys.
    Goldenthal EI; Cookson KM; Geil RG; Wazeter FX
    Cancer Chemother Rep 3; 1974 Sep; 5(1):15-6. PubMed ID: 4213302
    [No Abstract]   [Full Text] [Related]  

  • 18. Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents.
    Patel JB; Khandelwal A; Chopra P; Handratta VD; Njar VC
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):899-905. PubMed ID: 17345084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.